Brief: Amoeba and Viscus Biologics announce common program
27/06/2017 16:41
June 27 (Reuters) - AMOEBA SA AMEBA.PA :
* AMOEBA AND VISCUS BIOLOGICS ANNOUNCE COMMON PROGRAM TO
TREAT MULTI-RESISTANT BACTERIA
* SAYS PROGRAM IS FOR MULTI-RESISTANT BACTERIA IN HUMAN
WOUNDS
* PROJECT TARGETS THE UNITED STATES MARKET AS A FIRST
INSTANCE
Further company coverage: AMEBA.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Amoeba SA
See all newsBrief: Amoeba SA Obtained Convincing Results For Use Of Willaertia Magnac2c Maky Lysate In Cosmetic Skin Care, Has Filed Patent Application For Invention
French and Benelux stocks-Factors to watch
Brief: Amoeba: Final Stages Of Development Of 100% Biocontrol Plant In Cavaillon
Brief: Amoeba And Nissan Chemical Corp Announce Cooperation on Biocontrol
Brief: Amoeba FY Net Loss At EUR 8.0 Million